Navigation Links
KaloBios Appoints Donald R. Joseph as Chief Legal Officer
Date:6/17/2013

ved U.S. FDA Fast Track Designation.
  • KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

    For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

    Forward Looking Statements
    This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including:  the statements under the heading "Anticipated Upcoming Milestones for 2013-2014"; and statements regarding the company's clinical development of KB001-A, KB003 and KB004. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the company's
    '/>"/>

    SOURCE KaloBios Pharmaceuticals
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
    2. KaloBios Announces Fiscal Year 2012 Financial Results
    3. Organovo Appoints Tamar D. Howson to Board of Directors
    4. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
    5. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
    6. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
    7. Envera Appoints Michael McErlean Fermentation Manager
    8. WMIS Appoints Lisa Baird as Next Executive Director
    9. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
    10. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
    11. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/31/2014)... August 31, 2014 2014 ... is a professional and in-depth research report ... basic Polyacrylamide information, including Polyacrylamide definition, classification, ... as industry overview. This research covers the ... well as global industry analysis covering macroeconomic ...
    (Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... be valued at $5.6 billion in 2019. It ... 18.1% from 2013 to 2019, and was valued ... research report published by Transparency Market Research. , ... please visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research ...
    (Date:8/29/2014)... Livermore, California (PRWEB) August 29, 2014 ... Department of Energy's 2014 Hydrogen Production R&D ... photoelectrochemically -- by splitting water using sunlight. , ... Laboratory (NREL) and the University of Nevada, Las ... its work developing models of photoelectrochemical solar-hydrogen production ...
    (Date:8/28/2014)... 2014 Best Sanitizers, Inc., a leader ... processing industry, is asking industry professionals to prepare for ... the E2 soap they’re currently using to the Best ... Hand hygiene is critical to fighting cross-contamination and ... Six key criteria are identified to evaluate the effectiveness ...
    Breaking Biology Technology:International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Livermore Team Awarded for Hydrogen Production Research 2Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2
    ... (NYSE: DGX ), the nation,s leading provider ... is scheduled to speak,at the Lehman Brothers Eleventh ... at The Loews Miami Beach Hotel, Miami, Florida.,The ... 9:00 a.m.,Eastern Time., The presentation will be ...
    ... DIEGO, March 14 NuVasive, Inc. (Nasdaq:,NUVA), a medical ... treatments for the spine, announced today,that Kevin O,Boyle, Executive ... at the Lehman Brothers Eleventh Annual Global,Healthcare Conference at ... on,Wednesday, March 19, 2008 at 10:15 a.m. ET., ...
    ... webcast live and archived on Company,s web site, ... (Nasdaq: MBRK ), a pharmaceutical company focused ... Dr. Edward M. Rudnic, MiddleBrook president and CEO, ... 2008, at 4:45 p.m.,Eastern Time., The presentation ...
    Cached Biology Technology:Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference 2
    (Date:8/29/2014)... U.S. Ebola researcher from the University of Texas Medical Branch ... of three monoclonal antibodies can completely protect monkeys against a ... infection, at a time when the disease is severe. , ... editorial for Nature discussing advances in Ebola treatment ... are among the most deadly of pathogens, with fatality rates ...
    (Date:8/29/2014)... is available in German . ... between organisms is considered the oldest form of communication. ... conspecifics, for example, the sexual attraction between males and ... and to coordinate reproductive behavior in males and females. ... of the Algarve in Faro, Portugal, and at the ...
    (Date:8/29/2014)... The rise of the Tibetan plateau -- the largest ... important for both its profound effect on climate and ... in GSA Bulletin , Katharine Huntington and colleagues ... -- using modern and fossil snail shells to investigate ... Tibet. , Views range widely on the timing ...
    Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Ready for mating at the right time 2Ready for mating at the right time 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
    ... A study performed by the team of Dr. ... Unit at the IRCM, shows for the very first ... receptor, which is responsible for removing the bad cholesterol ... third protein, annexin A2. This major discovery co-authored by ...
    ... An international consortium of researchers has begun an effort ... gallopavo. The genome sequence will be obtained using the ... GS FLX Titanium PicoTiterPlate device and reagents. ... permits more than 1 million individual sequencing reads to ...
    ... than their parents because many of their genes for photosynthesis ... researchers from The University of Texas at Austin in a ... Their research has relevance in many areas of agriculture, and ... and seed production for animal feedstock and human consumption. ...
    Cached Biology News:A scientific breakthrough on the control of the bad cholesterol 2Research consortium to sequence turkey genome 2Research consortium to sequence turkey genome 3Research consortium to sequence turkey genome 4Plants grow bigger and more vigorously through changes in their internal clocks 2
    ... tray 19 x 29 cm, 1. ... processing.Automated staining of Coomassie Blue or silver-stain ... Prepares blots for high sensitivity ECL detection ... solution, volume, and processing time.Proven design for ...
    One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
    ... Designer designs oligos for SYBR Green, TaqMan, ... and FRET assays. Highly specific primers are ... automatically interpreting BLAST search results. Primer efficiency ... identified by connecting to the Mfold server. ...
    Human IL-17D Affinity Purified Polyclonal Ab...
    Biology Products: